Search

everythinglearnresearchcommunity

for

Search:↓

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Finasteride helps protect brain in old male rats.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Suppressing certain hormones might help prevent prostate cancer.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Treating PCOS is complex, involving medication like metformin and lifestyle changes, and requires attention to mental health due to high depression and anxiety rates.

Some common medications can harm male fertility, but many effects can be reversed.

Eclipta alba has many health benefits and contains compounds with potential for drug development.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Dianabol boosts muscle growth but has serious health risks and legal issues.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Progesterone boosts alcohol's effect on brain, finasteride counters it.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Human hair contains more glycosaminoglycans in children than adults, and these compounds decrease with age, possibly affecting hair thickness.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.